ABSTRACT The biologically active mediators of antigen-specific T suppressor cells can combine with antigen on cells that are specialized to present antigen (APC) and render these APC incapable ofpresenting not only the specific antigen that the product of the T suppressor cell sees but also any other antigen in or on the APC. Thus, antigen-bearing suppressed APC fail to activate either the helper or suppressor systems involved in the regulation of contact sensitivity responses. These results demonstrate that APC are targets of T suppressor cells. They also imply that a metabolic event is required for functional antigen presentation and that T suppressor cells can block that metabolic pathway.
Both Ly-1 T helper cells (1, 2) and suppressor inducer T cells (2) can be functionally inactivated by antigen-specific T suppressor (Ts) cells or their biologically active products (T suppressor factor, TsF). Ts cells have also been shown to be able to block the ability of B cells to secrete antibody (3, 4) . Antitumor effector functions performed by macrophages can also be inhibited by Ts cells (5) . It has even been suggested that Ts cells can inactivate helper factors (6) as well as helper cells. Thus, it is clear that the Ts cell set has multiple targets.
We have now asked whether antigen-presenting cells (APC) could be yet another target of the Ts cells' activity. To do this, we immunized mice with peritoneal exudate cells (PEC) labeled with 2,4,6-trinitrophenyl (TNP) and added Ts cells or TsF to the immunizing inocula. We tested the development ofcontact hypersensitivity (CS) of the immunized mice 7 days later. The suppressive material not only blocked the ability of the TNPlabeled APC to activate the cells responsible for CS but also blocked their ability to activate any detectable suppressor cells. Thus, TNP-labeled PEC, which on their own can activate both the helper and suppressor systems, fail to activate either system when incubated with Ts cells or TsF. As a result, Ts cells or TsF can guide antigen-bearing APC through the immunological apparatus so that no trace of the antigens ever having come in contact with the cells of the apparatus can be found. We have coined the term "immunological agnosis" to describe this phenomenon because it represents the opposite pole to immunological memory.
MATERIALS AND METHODS Animals. Male CBA mice obtained from a Polish supplier or from Jackson Laboratory were used throughout.
Chemicals. Picryl chloride (PCl, 2- (9) . ] TNP-specific TsF was prepared according to Zembala and Asherson (9) with minor modifications (10). Mice were injected twice i.v. with TNBSA and painted on the skin with 7% PCI in absolute alcohol on day 7, and on day 8 cultures of spleen and lymph node cells were prepared. Supernatants were harvested 2 days later and used as a source ofTsF. In some experiments, cells ofanimals that were only injected with TNBSA or only skin painted with PC1 were used (see Table 4 ).
Ox-specific TsF was prepared as described (7) . Briefly, mice were injected i.v. with 5 x 107 Ox-labeled thymocytes, and after 7 days the skin was painted with Ox (5% solution in absolute alcohol). One day later, cultures of spleen and lymph node cells were prepared and supernatants were harvested after 2 days. All cultures were prepared at a cell density of 1 Production of PEC-Derived Suppressive Material. A nonspecific suppressor monokine which inhibits the adoptive transfer of CS was produced as described (11) . Briefly, 10 PEC were incubated in 3 ml of TNP-specific TsF for 45 min at 370C and washed, and then 2 x 106 TNP-thymocytes in 1 ml of medium were added. Supernatants were collected after 45 min of incubation at 370C. TNP-immune cells that were to be used for adoptive transfer of CS were incubated in these supernatants for 45 min at 370C and then washed three times before transfer. Supernatants were also prepared by the reverse procedure, in which TNP-labeled PEC were incubated in TsF, washed, and then additionally incubated under the same conditions as above (see Table 6 ). Table 2 come from an experiment similar to the previous one (Table 1) individually labeled with two haptens, blocked the ability ofthe labeled PEC to present either hapten to the suppressor system (Table 4) , paralleling the findings of inhibition of antigen presentation to cells of the CS effector system (Table 2) .
RESULTS
Thus, incubation of the TNP-labeled PEC with TsF not only rendered the APC incapable of presenting antigens to the cells responsible for effecting CS but also blocked the ability of these APC to present antigens to the suppressor system.
Inability of the Subunits of Hapten-Specific TsF to Affect the Immunizing Capacity of Haptenated APC. Although our results showing that a single TsF could inhibit immunization with doubly labeled APC suggested that simple covering of antigenic determinants was not the mechanism by which TsF prevented immunization, we did some experiments to directly rule out this "trivial" explanation. To do this, we took advantage of the fact that the TNP TsF consists of two macromolecules, only one of which sees antigen, although both are required for biological TsF activity (13). Thus we asked if complete TsF was necessary to produce the inhibition ofimmunity or whether the antigen-binding portion of the TsF would be sufficient.
We found ( Table 5 ) that only the complete TsF or a mixture of its two subunits could inhibit the immune response induced by the TNP-labeled PEC. Similar findings were made when Ts cells were used instead of their biologically active factor. Thus, "blindfolding" of the APC cannot explain the phenomenon-of immunological agnosis that we have described.
Regulation by Hapten-Specific Ts Cells of the Ability of Haptenated Langerhans Cells to Induce CS. Because antigenlabeled PEC are not optimally suited to activate CS (7), we asked if the more efficient APC, cutaneous Langerhans cells (7), would also fail to immunize after hapten labeling and in- cubation withTsF? The data in Table 6 indicate that they did. release informational molecules of a suppressive nature. As a consequence of suppression of the APC, the antigens they are supposed to present pass through the immune apparatus without leaving behind a trace ofever having been there. Thus, mice immunized with haptenated APC with TsF on them are neither immunized nor tolerized in respect to the immune phenomenon of CS. Because mice immunized as above do not mount significant antibody responses, we must use other modes ofimmunization to see if the humoral arm of the immune response will also show agnosis.
We have been able to rule out blindfolding of the antigen on the APC by antigen-binding Ts-cell-released material as an explanation for agnosis by virtue of the fact that the TsF under study is composed of two separate macromolecules, only one of which binds antigen (13) . The effects we have presented require complete factor (both macromolecules). If one uses the macromolecule that binds antigen only, there is no change in the immunogenic capacity of the haptenated APC.
To better understand how the event we have described could bebrought about physiologically, one point deserves emphasis: the TsF under study can bind to macrophages in the absence ofantigen (15) . Thus, APC incubated in TsF first and then challenged with antigen release a nonspecific suppressive molecule (11) . However, in the experiments reported above, we have done the opposite, we have labeled the macrophages with antigen first and then added suppressor factor. This reversal of treatments leads to a completely different effect: in the former case the PEC are armed to produce suppression and in the latter case they are themselves suppressed (e.g., see Table 7 ). Thus, the effect that an antigen-specific TsF will have depends on which part of the molecule engages receptors on the macrophage membrane; if the factor reacts with an Fc-like receptor (15) it passively arms the macrophage. When this "passive receptor" is engaged by specific antigen a signal is transduced and the macrophage then performs its immunological duties. However, when the suppressor factor binds to its specific antigen that is already in or on the macrophage a reverse effect occurs. Under these conditions, the function inherent in the suppressor factor is activated and the result is that the antigen-bearing cell becomes "inactivatable" by transducing signal (i.e., it is suppressed). Thus, TsF has at least two intrinsic properties and one element that determines which of these activities will predominate depends on which part ofthe molecule is engaged. Under one circumstance it can act as a passive receptor without bringing forth its intrinsic "suppressive" activity on the APC. Under other circumstances its suppressive activity is focused on the APC and then the APC with which it interacts can no longer present antigen to either of the two major arms of the immune system.
Because haptenated dead cells or haptenated proteins do not produce immunological agnosis (i.e., they help, suppress, or paralyze immune responses), one must question why haptenated APC with TsF on them fail to present antigen in general, or to the suppressor system in particular. Our explanation is that APC must do more than simply present-antigen to the inducer cells of any of the immunological circuits. In addition to presentation, they must make a product that allows the inducer cell that is reacting with the antigen being presented to be activated. The TsF prevents the APC from making this product. In the other instances cited above, the antigen will probably be processed by the host system and host APC will then present the antigen to the appropriate inducer cells of the various immunological circuits. However, haptenated PEC incubated in TsF are most likely incapable of being processed by the host in a way that the hapten can be presented on the host's own live cells (7) . As a consequence ofthe inability ofhaptenated PEC to present the antigen and the inability of the host to process haptenated PEC, the hapten on the suppressed APC appears as if it were unseen by inducer cells of any of the immunological circuits; when antigen is reintroduced on a cell that is capable of presenting the antigen to the immune system, the immune response that follows gives no evidence that the system had previously been in contact with antigen. Thus, it could be said to have forgotten, or perhaps never learned, that it had ever seen antigen. "Immunological agnosis" is an appropriate term to identify this phenomenon.
